Linda M. Richardson - Feb 14, 2022 Form 4 Insider Report for INTERCEPT PHARMACEUTICALS, INC. (ICPT)

Role
EVP & Chief Commercial Officer
Signature
/s/ Rocco Venezia, as attorney-in-fact
Stock symbol
ICPT
Transactions as of
Feb 14, 2022
Transactions value $
-$7,856
Form type
4
Date filed
2/15/2022, 03:48 PM
Previous filing
Jan 31, 2022
Next filing
Feb 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICPT Common Stock Tax liability -$7.86K -529 -1.53% $14.85 34.1K Feb 14, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.